Endoscopic Mucosal Resection Market Size, Share, Growth, and Industry Analysis, By Type (Entry Needle, Mucosectomy Snare, Probe, and Other), By Application (Hospitals, Ambulatory Surgical Centers, Surgical Centers, Others), Regional Insights and Forecast To 2032

• 

   Request a Free Sample To Get More Information on this Market

Endoscopic Mucosal Resection Market Report Overview

global endoscopic mucosal resection market size was USD 1.89 billion in 2023 and market is projected to touch USD 3.74 billion by 2032 at CAGR 7.9% during the forecast period.

Endoscopic mucosal resection (EMR) is a minimally invasive procedure used to remove abnormal or precancerous growths in the gastrointestinal tract. It is commonly performed in the esophagus, stomach, and colon. EMR is an alternative to surgical resection and allows for the removal of abnormal tissues without the need for major surgery. The endoscope is equipped with specialized tools, such as a snare or a suction device, which are used to grasp and remove the abnormal tissue.

The targeted tissue is typically lifted or suctioned into a cap or snare, and then cut or burned away from the underlying layers. Advantages of EMR include its minimally invasive nature, shorter recovery time compared to surgery, and avoidance of more extensive procedures. However, EMR may not be suitable for larger tumors or lesions that have invaded deeper layers of the gastrointestinal wall. In such cases, other treatment options like endoscopic submucosal dissection (ESD) or surgical resection may be recommended.

COVID-19 IMPACT: Increased Infection Control Measures to Boost Demand Significantly

COVID-19 had a life changing impact globally. The endoscopic mucosal resection market was significantly affected. The virus had various impacts on different markets. Lockdowns were imposed in several nations. This erratic pandemic caused disruptions on all sorts of businesses. Restrictions tightened during the pandemic due to increasing number of cases. Numerous Industries were affected. However, the market for endoscopic mucosal resection experienced an increased demand.

Lockdowns, restrictions, and overwhelmed healthcare systems have limited patient access to healthcare facilities. This has resulted in delayed diagnoses, including the identification of abnormal growths that would require endoscopic mucosal resection. Reduced access to care may have resulted in the progression of certain conditions, potentially requiring more invasive treatment options.

Endoscopic procedures like endoscopic mucosal resection carry a risk of spreading infections, including COVID-19. To minimize this risk, healthcare facilities have implemented enhanced infection control measures, such as pre-procedure screening, personal protective equipment (PPE) requirements, and disinfection protocols. These measures may have impacted the workflow, efficiency, and scheduling of EMR procedures.

LATEST TRENDS

"Enhanced Imaging Capabilities to Broaden Market Growth"

Several advanced imaging techniques, such as narrow-band imaging (NBI), chromoendoscopy, and confocal laser endomicroscopy (CLE), have been developed to improve the detection and characterization of abnormal lesions. These techniques help endoscopists better visualize the borders and characteristics of the lesions, enabling more precise and targeted endoscopic mucosal resection procedures.

Hybrid endoscopic techniques combine different endoscopic approaches, such as endoscopic mucosal resection and ESD, to optimize lesion removal. For instance, a combination of EMR and ESD may be employed to perform a partial ESD followed by endoscopic mucosal resection for complete resection. These hybrid techniques aim to balance efficacy and safety, especially for larger or challenging lesions. These latest developments are anticipated to boost the endoscopic mucosal resection market share.

Endoscopic Mucosal Resection Market Segmentation

• By Type

Based on type, the market is divided into entry needle, mucosectomy snare, probe, and other.

Entry needle holds a major share of the global market.

• By Application

Based on application, the market is bifurcated into hospitals, ambulatory surgical centers, surgical centers, others.

Hospitals as application holds a major share of the global market.

DRIVING FACTORS

"Minimal Invasive Nature to Boost Market Share"

EMR is a minimally invasive procedure that can be performed using an endoscope, avoiding the need for open surgery. This approach offers several advantages, including reduced postoperative pain, shorter hospital stays, quicker recovery times, and minimal scarring. EMR can often be an alternative to more invasive surgical procedures, such as partial organ resections. EMR can help avoid the potential complications associated with major surgery, including risks of infection, bleeding, and prolonged recovery.

"Early Diagnosis and Therapeutic Capabilities to Boost Market Size"

EMR is particularly effective in the early detection and removal of abnormal growths, such as precancerous polyps or early-stage cancers, in the gastrointestinal tract. Early detection allows for a higher chance of successful treatment and improved patient outcomes. EMR serves both diagnostic and therapeutic purposes. It can be used to obtain tissue samples for accurate diagnosis and staging of diseases, while also providing a definitive treatment option for small lesions and early-stage cancers. These factors are anticipated to drive the endoscopic mucosal resection market share.

RESTRAINING FACTORS

"Inadequate Lesion Staging to Hamper Market Share"

Accurate staging and characterization of the lesion are crucial for determining the appropriate treatment approach. In some cases, EMR may not be suitable if there is uncertainty about the nature of the lesion or its potential for deeper involvement. Additional diagnostic tests, such as endoscopic ultrasound (EUS) or advanced imaging modalities, may be necessary to improve the assessment and guide treatment decisions. The factors are anticipated to hinder the growth of the endoscopic mucosal resection market share.

• 

   Request a Free Sample To Get Analysis on Major Geographic Market
•  

Endoscopic Mucosal Resection Market Regional Insights

"Asia-Pacific Dominates the Endoscopic Mucosal Resection Market "

APAC is the largest market shareholder for endoscopic mucosal resection market share. The Asia-Pacific region has a relatively high prevalence of gastrointestinal diseases, such as gastric cancer, colorectal cancer, and esophageal cancer. These conditions often require endoscopic interventions, including EMR, for diagnosis, staging, and treatment. The larger patient population with these conditions in the region contributes to a higher demand for EMR procedures. North America is the second major shareholder for the endoscopic mucosal resection share.

KEY INDUSTRY PLAYERS

"Market Players Focus on New Product Launches to Strengthen Market Position"

Leading players in the market are adopting various strategies to expand their presence in the market. These include R&D investments and launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.   

LIST OF TOP ENDOSCOPIC MUCOSAL RESECTION COMPANIES

• CONMED [U.S.]
• Boston Scientific Corp. [U.S.]
• Cook Medical [U.S.]
• Erbe Elektromedizin GmbH [Germany]
• Interscope Medical [U.S.]
• Olympus [Japan]
• STERIS [U.S.]
• Sumitomo Bakelite Co., Ltd. [Japan]

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.